Nektar Therapeutics: Executives
Howard W. RobinPresident and Chief Executive OfficerFY2022
Mark A. WilsonFormer Chief Legal OfficerFY2022
Jonathan Zalevsky, Ph.D.Chief Research and Development OfficerFY2022
Sandra GardinerInterim Chief Financial OfficerNot disclosed—
4 executives

Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.